Real-time insights. Smarter decisions. Better trades.
🔍 Search StocksConfidence: 65.00%
Date: 19-05-2026
Price: $16.490
Last Price: $16.470
Post-Signal Low Price: $16.470
This article first appeared on GuruFocus. Revenue: Increased 13% to $6.8 billion. Underlying EBITDA: Increased 3.2% to $300 million. Healthcare EBITDA: Up 1.3% to $254 million. Animal Care EBITDA: Grew 15.1% to $68 million. Underlying NPAT: $125 million, down slightly due to DC capital renewal prog
As global markets grapple with economic uncertainty and inflation concerns, investors are increasingly looking towards Asia for opportunities, particularly in the realm of dividend stocks. In this environment, a strong dividend yield can provide a buffer against market volatility and offer a steady
With its stock down 11% over the past month, it is easy to disregard EBOS Group (NZSE:EBO). However, the company's fundamentals look pretty decent, and long-term financials are usually aligned with future market price movements. Specifically, we decided to study EBOS Group's ROE in this article. R
The board of EBOS Group Limited (NZSE:EBO) has announced that it will pay a dividend of A$0.5951 per share on the 21st of March. Based on this payment, the dividend yield on the company's stock will be 3.2%, which is an attractive boost to shareholder returns. View our latest analysis for EBOS Grou
Shareholders might have noticed that EBOS Group Limited (NZSE:EBO) filed its interim result this time last week. The early response was not positive, with shares down 6.7% to NZ$39.00 in the past week. Results overall were respectable, with statutory earnings of AU$1.42 per share roughly in line wit
Chart available once enough post-signal price data is available.
AI Confidence - 65.00 % model confidence
EBOS Group Limited is a leading healthcare and pharmaceutical distributor in Australia and New Zealand, serving hospitals, pharmacies, and healthcare providers. The company operates across multiple segments including medical, pharmaceutical, and animal care, maintaining a strong market position through extensive distribution networks and strategic acquisitions.
| Cash Flow | Moderate |
| Debt | Moderate |
| Profitability | Moderate |
| Revenue Trend | Uptrend |
| Trend | Bearish |
| Momentum | Weak |
| RSI Signal | Neutral |
| Support Level | $ 16.00 |
| Resistance Level | $ 17.50 |